Humanization of antibodies

被引:158
作者
Almagro, Juan C. [1 ]
Fransson, Johan [2 ]
机构
[1] Centocor Inc, R&D, Radnor, PA 19087 USA
[2] Centocor Discovery Res, San Diego, CA 92121 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2008年 / 13卷
关键词
immunoglobulins; Igs; hypervariable loops; framework; FR; complementarity determining regions; CDR; SRD; canonical structures; CDR grafting; SDR grafting Resurfacing; Superhumanization; Guided Selection; Humaneering; Framework Shuffling; review;
D O I
10.2741/2786
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Humanization has played a fundamental role in the remarkable progress of antibodies as therapeutic reagents. Here we have reviewed the publications on antibody humanization since the first report on CDR grafting in the second half of the 1980's up to June 2007. We describe the two main trends in the field: rational and empirical methods to humanize antibodies. Rational methods rely on the so-called design cycle. It consists of generating a small set of variants, which are designed based on the antibody structure and/or sequence information, and assessing their binding or any other characteristic of interest. Rational methods include CDR grafting, Resurfacing, Superhumanization and Human String Content Optimization. In contrast to rational methods, empirical methods are based on generating large combinatorial libraries and selecting the desired variants by enrichment technologies such as phage, ribosome or yeast display, or by high throughput screening techniques. The latter methods rest on selection rather than making assumptions on the impact of mutations on the antibody structure. These methods include Framework Libraries, Guided Selection, Framework Shuffling and Humaneering.
引用
收藏
页码:1619 / 1633
页数:15
相关论文
共 109 条
[1]  
ALFENITO M, 2007, CONVERSION NONHUMAN
[2]   Standard conformations for the canonical structures of immunoglobulins [J].
AlLazikani, B ;
Lesk, AM ;
Chothia, C .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 273 (04) :927-948
[3]   Structural differences between the repertoires of mouse and human germline genes and their evolutionary implications [J].
Almagro, JC ;
Hernández, I ;
Ramírez, MD ;
Vargas-Madrazo, E .
IMMUNOGENETICS, 1998, 47 (05) :355-363
[4]   Identification of differences in the specificity-determining residues of antibodies that recognize antigens of different size: implications for the rational design of antibody repertoires [J].
Almagro, JC .
JOURNAL OF MOLECULAR RECOGNITION, 2004, 17 (02) :132-143
[5]   The differences between the structural repertoires of VH germ-line gene segments of mice and humans:: Implication for the molecular mechanism of the immune response [J].
Almagro, JC ;
Hernandez, I ;
Ramirez, MD ;
Vargas-Madrazo, E .
MOLECULAR IMMUNOLOGY, 1997, 34 (16-17) :1199-1214
[6]   Design and validation of a synthetic VH repertoire with tailored diversity for protein recognition [J].
Almagro, Juan Carlos ;
Quintero-Hernandez, Veronica ;
Ortiz-Leon, Mauricio ;
Velandia, Alvaro ;
Smith, Sylvia L. ;
Becerril, Baltazar .
JOURNAL OF MOLECULAR RECOGNITION, 2006, 19 (05) :413-422
[7]   3-DIMENSIONAL STRUCTURE OF IMMUNOGLOBULINS [J].
AMZEL, LM ;
POLJAK, RJ .
ANNUAL REVIEW OF BIOCHEMISTRY, 1979, 48 :961-997
[8]   Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagent [J].
Asano, Ryutaro ;
Sone, Yukiko ;
Makabe, Koki ;
Tsumoto, Kouhei ;
Hayashi, Hiroki ;
Katayose, Yu ;
Unno, Michiaki ;
Kudo, Toshio ;
Kumagai, Izumi .
CLINICAL CANCER RESEARCH, 2006, 12 (13) :4036-4042
[9]  
Baca M, 1997, J BIOL CHEM, V272, P10678
[10]   Isolating human antibody against human hepatocellular carcinoma by guided-selection [J].
Bao, GQ ;
Li, Y ;
Ma, QJ ;
He, XL ;
Xing, JL ;
Yang, XM ;
Chen, ZN .
CANCER BIOLOGY & THERAPY, 2005, 4 (12) :1374-1380